Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naval Daver

Showing results (141-150 of 436) with videos related to

Pageof 44
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|July 14, 2018
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic SyndromeFevzi Firat Yalniz, Naval Daver, Katayoun Rezvani, et al.
American Journal of Hematology|February 12, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemiaJayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero, et al.
Frontiers in Cellular and Infection Microbiology|April 18, 2022
Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia PatientsSamantha Franklin, Samuel L Aitken, Yushi Shi, et al.
Blood|June 7, 2021
Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasmNaveen Pemmaraju, Nathaniel R Wilson, Joseph D Khoury, et al.
American Journal of Hematology|May 18, 2018
Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid LeukemiaBrenda Chyla, Naval Daver, Kelly Doyle, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 24, 2013
Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemiaPaolo Strati, Naval Daver, Farhad Ravandi, et al.
Nature Reviews. Clinical Oncology|February 14, 2018
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 21, 2017
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive LeukemiaRita Assi, Hagop Kantarjian, Nicholas J Short, et al.
Cancer|June 17, 2017
A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adultsNaval Daver, Kenneth McClain, Carl E Allen, et al.
Blood Cancer Journal|February 1, 2022
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cellsWarren Fiskus, Taghi Manshouri, Christine Birdwell, et al.
Pageof 44

Showing results (141-150 of 436) with videos related to

Sort By:
Pageof 44
Clinical Lymphoma, Myeloma & Leukemia|July 14, 2018
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic SyndromeFevzi Firat Yalniz, Naval Daver, Katayoun Rezvani, et al.
American Journal of Hematology|February 12, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemiaJayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero, et al.
Frontiers in Cellular and Infection Microbiology|April 18, 2022
Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia PatientsSamantha Franklin, Samuel L Aitken, Yushi Shi, et al.
Blood|June 7, 2021
Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasmNaveen Pemmaraju, Nathaniel R Wilson, Joseph D Khoury, et al.
American Journal of Hematology|May 18, 2018
Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid LeukemiaBrenda Chyla, Naval Daver, Kelly Doyle, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 24, 2013
Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemiaPaolo Strati, Naval Daver, Farhad Ravandi, et al.
Nature Reviews. Clinical Oncology|February 14, 2018
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 21, 2017
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive LeukemiaRita Assi, Hagop Kantarjian, Nicholas J Short, et al.
Cancer|June 17, 2017
A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adultsNaval Daver, Kenneth McClain, Carl E Allen, et al.
Blood Cancer Journal|February 1, 2022
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cellsWarren Fiskus, Taghi Manshouri, Christine Birdwell, et al.
Pageof 44